This company has been marked as potentially delisted and may not be actively trading. Amedica (AMDA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock AMDA vs. INFU, NSPR, CTCX, TMDIF, HSAQ, GBS, RVP, PETV, BTCY, and IVFShould you be buying Amedica stock or one of its competitors? The main competitors of Amedica include InfuSystem (INFU), InspireMD (NSPR), Carmell (CTCX), Titan Medical (TMDIF), Health Sciences Acquisitions Co. 2 (HSAQ), GBS (GBS), Retractable Technologies (RVP), PetVivo (PETV), Biotricity (BTCY), and INVO Fertility (IVF). These companies are all part of the "medical" sector. Amedica vs. Its Competitors InfuSystem InspireMD Carmell Titan Medical Health Sciences Acquisitions Co. 2 GBS Retractable Technologies PetVivo Biotricity INVO Fertility Amedica (NASDAQ:AMDA) and InfuSystem (NYSE:INFU) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability. Do insiders & institutionals hold more shares of AMDA or INFU? 3.7% of Amedica shares are held by institutional investors. Comparatively, 71.1% of InfuSystem shares are held by institutional investors. 0.9% of Amedica shares are held by insiders. Comparatively, 11.4% of InfuSystem shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has preferable earnings and valuation, AMDA or INFU? InfuSystem has higher revenue and earnings than Amedica. Amedica is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmedica$11.23M4.60-$9.32M-$3.13-1.39InfuSystem$139.89M1.46$870K$0.2343.43 Do analysts recommend AMDA or INFU? InfuSystem has a consensus target price of $12.50, suggesting a potential upside of 25.13%. Given InfuSystem's stronger consensus rating and higher probable upside, analysts clearly believe InfuSystem is more favorable than Amedica.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amedica 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00InfuSystem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 3 Strong Buy rating(s) 4.00 Which has more volatility & risk, AMDA or INFU? Amedica has a beta of -1.24, meaning that its stock price is 224% less volatile than the S&P 500. Comparatively, InfuSystem has a beta of 1.82, meaning that its stock price is 82% more volatile than the S&P 500. Does the media refer more to AMDA or INFU? In the previous week, InfuSystem had 2 more articles in the media than Amedica. MarketBeat recorded 3 mentions for InfuSystem and 1 mentions for Amedica. InfuSystem's average media sentiment score of 1.64 beat Amedica's score of 0.00 indicating that InfuSystem is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amedica 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InfuSystem 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is AMDA or INFU more profitable? InfuSystem has a net margin of 1.12% compared to Amedica's net margin of -139.62%. InfuSystem's return on equity of 2.78% beat Amedica's return on equity.Company Net Margins Return on Equity Return on Assets Amedica-139.62% -148.60% -67.83% InfuSystem 1.12%2.78%1.41% SummaryInfuSystem beats Amedica on 15 of the 16 factors compared between the two stocks. Get Amedica News Delivered to You Automatically Sign up to receive the latest news and ratings for AMDA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AMDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMDA vs. The Competition Export to ExcelMetricAmedicaSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$51.63M$78.06M$5.84B$10.14BDividend YieldN/AN/A5.68%4.60%P/E Ratio-1.3911.4075.4125.98Price / Sales4.6080.37513.64284.11Price / CashN/A18.4137.5660.44Price / Book2.4210.9312.156.29Net Income-$9.32M-$26.48M$3.29B$271.07M Amedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMDAAmedicaN/A$4.35-4.2%N/A+6.9%$51.63M$11.23M-1.39N/ANews CoverageGap UpINFUInfuSystem3.3545 of 5 stars$10.13+0.3%$12.50+23.4%+53.9%$206.92M$139.89M168.86410Positive NewsNSPRInspireMD3.6448 of 5 stars$2.42+0.8%$4.50+86.0%-12.5%$100.13M$7.07M-3.2350News CoveragePositive NewsShort Interest ↓CTCXCarmellN/A$2.74+5.0%N/A+307.7%$57.28M$32.84K0.0014TMDIFTitan MedicalN/A$0.36+11.8%N/A+990.4%$41.28M$17.63M-0.2950HSAQHealth Sciences Acquisitions Co. 2N/A$2.61-3.7%N/A-55.5%$29.26MN/A0.004GBSGBSN/A$1.70-3.4%N/A-10.5%$25.31MN/A-3.047News CoverageRVPRetractable Technologies1.2294 of 5 stars$0.81-1.1%N/A-9.7%$24.28M$38.16M-1.50240Short Interest ↑High Trading VolumePETVPetVivoN/A$0.87+2.4%N/A+50.8%$24.25M$1.05M-1.9320News CoverageBTCYBiotricityN/A$0.73+10.1%N/A+86.4%$18.18M$12.06M-0.6840IVFINVO Fertility0.2251 of 5 stars$1.02+1.0%N/A-95.9%$4.41M$6.53M-0.0110News CoverageGap Down Related Companies and Tools Related Companies InfuSystem Competitors InspireMD Competitors Carmell Competitors Titan Medical Competitors Health Sciences Acquisitions Co. 2 Competitors GBS Competitors Retractable Technologies Competitors PetVivo Competitors Biotricity Competitors INVO Fertility Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AMDA) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredAmerica’s most terrifying chart?MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedica Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
